Anna C. Virgili
Barcelona, CT 08041, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Immune phenotype and RAS/BRAF status predict outcomes after lung metastasectomy for colorectal cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 13, 2026
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial.
Journal: Lancet (London, England)
Published: August 29, 2025
Predictive factors of efficacy for FTD/TPI plus bevacizumab in refractory metastatic colorectal cancer patients: a subanalysis of the Spanish cohort from the SUNLIGHT phase III trial.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: December 20, 2024
A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation.
Journal: International journal of nanomedicine
Published: October 03, 2024
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas.
Journal: Diagnostics (Basel, Switzerland)
Published: April 25, 2024
Monitoring of adverse effects and quality of life during chemotherapy treatment through the EMMA Salud mobile App in patients with colorectal cancer
Journal: Medicina clinica
Published: April 12, 2024
Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
Journal: The British journal of surgery
Published: March 07, 2023
Frequency and clinical relevance of DPYD genetic variants in gastrointestinal cancer patients.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: April 05, 2022
ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients.
Journal: Frontiers in pharmacology
Published: April 07, 2020
Last Updated: 09/26/2026